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Abstract Developments in prenatal testing allow the detec-
tion of more findings. SNP arrays in prenatal diagnosis (PND)
can be analyzed at 0.5 Mb resolution detecting more clinically
relevant anomalies, or at 5 Mb resolution. We investigated
whether women had sufficient knowledge to make informed
choices regarding the scope of their prenatal test that were
consistent with their attitude. Pregnant women could choose
between testing at 5 or at 0.5 Mb array. Consenting women
(N = 69) received pre-test genetic counseling by phone and
filled out the Measure of Informed Choice questionnaire de-
signed for this study. Choices based on sufficient knowledge
and consistent with attitude were considered informed. Sixty-
two percent of the women made an adequately informed
choice, based on sufficient knowledge and attitude-
consistent with their choice of microarray resolution.
Womenwhomade an informed choice, opted for 0.5Mb array
resolution more often. There were no differences between
women making adequately informed or less informed choices
regarding level of experienced anxiety or doubts. Over time
on T0 and T1, anxiety and doubts significantly decreased.
While previous studies demonstrated that knowledge is an
important component in informed decision-making, this study
underlines that a consistent attitude might be equally impor-
tant for decision-making.We advocate more focus on attitude-
consistency and deliberation as compared to only a strong
focus on knowledge.
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Introduction
Prenatal genetic screening and follow-up diagnostic testing
confront pregnant women with often difficult decisions. One
of the first decisions women make is whether or not to partic-
ipate in prenatal screening. When deliberating whether or not
to participate in prenatal screening programs, many women
may find it difficult to understand the characteristics of the
test, to weigh its benefits and risks and to grasp the possible
implications (van Schendel et al. 2015).
The use of new, increasingly complex techniques, it is
feared, may further hinder informed choices (de Jong et al.
2013, 2014; Dondorp et al. 2015). To date, there has been little
empirical evidence to support or falsify the concern that wom-
en may no longer be able to make informed decisions regard-
ing more complex prenatal tests. While techniques in prenatal
screening and diagnosis are developing rapidly, the need for
insight into whether pregnant women are making informed
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choices about prenatal genetic testing becomes ever more
pressing.
The stated aim of prenatal screening is to offer reproductive
options, allowing pregnant women to choose the best course
of action if their unborn child is affected (Dondorp et al.
2015). These actions may include preparing for the future,
altering pregnancy management or terminating a pregnancy.
Prenatal screening and diagnosis should thus provide informa-
tion about the fetus that is relevant to reproductive decision-
making. Information that is not relevant to reproductive deci-
sion-making, it is argued, consequently falls outside the scope
of prenatal screening (Dondorp et al. 2012). Information out-
side of this scope can be unwanted, for it may be burdensome
and could lead to worry or anxiety for pregnant women.
Moreover, such information may needlessly infringe upon
their child’s right not to know its genetic risk (de Jong et al.
2014; Dondorp et al. 2012). Although the scope of prenatal
screening should thus be limited to information that is relevant
to reproductive decision-making, what is considered to be
relevant is a topic for debate.
At present, in the Netherlands, prenatal screening is limited
to detecting an increased risk of trisomies 13, 18 and 21.
However, in our center we employ whole genome SNP arrays
for prenatal diagnosis. One of the major consequences of
using SNP array instead of more targeted techniques (such
as rapid aneuploidy detection or conventional karyotyping)
is that many more genetic aberrations may be detected (e.g.,
early onset diseases such as Williams syndrome, and
Duchenne muscular dystrophy). Genetic aberrations may
even include susceptibility loci (SL: 1.4%) (Van Opstal et al.
2015). SL are complicated test results because although they
are defined as Blikely pathogenic^ (Srebniak et al. 2014), the
associated risk of expression and severity is yet unquantifi-
able. SL are associated with neurodevelopmental disorders
such as learning disabilities, behavioral problems and/or sei-
zures (Srebniak et al. 2011; Van Opstal et al. 2015). We re-
ported on the first parents’ experiences with prenatal disclo-
sure of SL in a previous study (van der Steen et al. 2016).
Outcomes like these may be equally relevant to reproductive
decision-making. There is tension between the legal scope of
prenatal screening in the Netherlands and its stated aim of
enabling reproductive autonomy. There is also a tension be-
tween the scope of SNP array for follow-up diagnostic testing
at our clinic, and the scope of screening in the national prena-
tal screening program, which is much narrower.
This contentious topic leads to much discussion amongst
professionals and ethicists about which test to employ and
what to report to pregnant women regarding prenatal genetic
test outcomes. Some emphasize that test results which fall
outside the scope of prenatal screening might put an unneces-
sary burden on pregnant couples (de Jong et al. 2014), while
others argue that withholding any kind of information is pa-
ternalistic and should be avoided (McGillivray et al. 2012).
A prerequisite for reproductive autonomy is making an
informed choice.Marteau et al. (2001) state that BAn informed
decision is one where all the available information about the
health alternatives is weighed up and used to inform the final
decision; the resulting choice should be consistent with the
individual’s values. An effective decision is one that is in-
formed, consistent with the decision-maker’s values and be-
haviorally implemented^ (p. 100). Well-informed choices are
psychologically beneficial (Kleinveld et al. 2009; van den
Berg et al. 2006). Psychological management of prenatal test
decisions is better when knowledge is adequate (Dahl et al.
2011), while uninformed choices increase decisional conflict
and decrease feelings of personal wellbeing (Dahl et al. 2011).
Psychological coping and informed choice were more difficult
for pregnant women who were not prepared for the possibility
of an abnormal prenatal screening result (Kleinveld et al.
2009). Studies reported that a majority of pregnant women
did not make informed decisions regarding prenatal screening.
And most women did not have sufficient knowledge to pre-
pare them for the possibility of abnormal outcomes of prenatal
screening (McCoyd 2013; Schoonen et al. 2011). Without
adequate information provision and counseling, offering pre-
natal diagnosis with a wider scope could indeed burden the
pregnant couple and undermine their reproductive autonomy
instead of enhancing it. Making informed choices is meant to
prevent the harms that too much unwanted information could
cause.
What pregnant couples wish to learn about the health of
their fetus is underreported thus far. The few studies on this
subject indicate a preference among pregnant couples to learn
as much as possible from prenatal diagnosis (PND) (Riedijk
et al. 2014; van der Steen et al. 2014). We have recently report-
ed that the vast majority of pregnant couples to whom we had
offered the choice between array at higher (0.5 Mb) or lower
resolution (5 Mb, comparable to CK), chose higher resolution
array. In our experience, most pregnant couples at increased
risk for common aneuploidies chose to learn as much as pos-
sible about the (future) health of their unborn child (van der
Steen et al. 2014). We furthermore offered couples a choice
whether they wished to be informed of SL if detected.
Eighty-four percent of the pregnant couples engaging in PND
chose to be informed of SL should these be detected (van der
Steen et al. 2014). Using SNP arrays as a diagnostic prenatal
test leads to the poignant question of the extent to which preg-
nant couples have sufficient knowledge to make informed de-
cisions regarding its scope (van der Steen et al. 2014).
In this study we report on one member of pregnant couples,
that is, pregnant women at increased risk for common aneu-
ploidies who were offered a choice between 0.5 and 5 Mb
SNP array testing.We investigatedwhether they had sufficient
knowledge to make an informed decision consistent with their
attitude. Furthermore, we explored whether level of informed
choice was associated with anxiety and doubts.
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Materials and Methods
Participants
Pregnant women (N = 69) consented to participate from
February 2012 to September 2013 at our outpatient prenatal
clinic. Inclusion criteria were: a) advanced maternal age
(>36 years), and/or b) the woman participated in first-
trimester prenatal screening (PNS) or PND, and c) fluency in
Dutch language. Women were approached at the intake of their
first ultrasound, around 9–11 weeks gestational age (GA) and
counseled by a clinical geneticist (see Fig. 1 for a timeline of the
study). After counseling, women filled out a questionnaire
about their choice. The Measure of Informed Choice, see
Measures section, was filled out by a subsample of women that
participated in our previous study (van der Steen et al. 2014).
Procedure
This study was waivered by the local Medical Ethical Testing
Committee (METC). An information leaflet about the study
was added to the invitation letter pregnant women received
before attending the outpatient clinic. A research-assistant was
present at the clinic to approach pregnant women meeting the
inclusion criteria and provide information concerning the
study and its further procedures. After consenting, an addi-
tional genetic counseling session with a clinical geneticist by
telephone was planned in advance of the next appointment for
PNS or PND. We combined women engaging in PNS (hypo-
thetical choice) and PND (real choice) in our sample to obtain
a larger number of participants. Face-to-face counseling was
not practically feasible in this study.
Women were approached at the intake around 9–11 weeks
gestational age (GA) and counselled by a clinical geneticist,
after which they filled out a questionnaire (T0) (see Fig. 1).
Between 16 and 23 weeks GA, women were approached for
follow-up by phone. This was four weeks after their prenatal
test results (T1).
Content of Genetic Counseling by Telephone
Participating women received a 30–45 min counseling from a
clinical geneticist (or a resident) by phone. Extensive
information was provided. In addition to the background of
genetics, participants were informed of the difference between
5 Mb and 0.5 Mb array. The 5 Mb array was presented as a
Bless broad test,^ and it was specified that trisomy 13, 18 and
21 and other microscopically visible deviations could be
found, comparable to the scope of a karyotype. The 0.5 Mb
array was presented as a Bbroader test,^ and examples of what
could be detected additionally by broader testing compared to
less broad testing was illustrated with Williams syndrome,
Duchenne muscular dystrophy, and susceptibility loci for
neurodevelopmental disorders (SL); these were counseled as
incidental findings. Initially, participants could choose be-
tween 5 Mb testing and 0.5 Mb testing. The 0.5 Mb array
resolution was presented as a broader test that also included
susceptibility loci. During data collection, an increasing num-
ber of participants wished to learn the results of 0.5 Mb reso-
lution array, but without disclosure of susceptibility loci.
Therefore, we adopted the policy that participants could also
opt for 0.5 Mb (broader testing) without being informed of
susceptibility loci. The last part of the counseling comprised a
dialogue about the women’s concerns, attitudes towards the
scope of testing, questions and preferences. Women were
asked whether they already knew what resolution they would
choose. If necessary, additional information or explanation
was provided.
Measures
Demographics
Socio-demographic data were collected (living situation, edu-
cational level, nationality, religion, and age).
Measure of Informed Choice
To explore informed decision making regarding the scope of
PND, we developed the Measure of Informed Choice (MIC).
The MIC is based on the Multi-dimensional Measure of
Informed Choice instrument [MMIC, Knowledge Scale
(α = .68), and Attitude Scale (α = .78)] by Michie et al.
(2002), which measures knowledge and attitude towards
PNS. Our MIC contains 7 items measuring knowledge (see
Table 2) and 6 attitude items regarding the scope of PND (see
Fig. 1 Timeline of the study
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Table 3). A decision was considered to be adequately in-
formed if it was based on sufficient knowledge and if the
decision was consistent with the attitude towards testing with
higher or lower resolution array. The knowledge scale com-
prised multiple-choice items, and we determined a cut-off
score of 5 or more correct answers to qualify as Badequate
knowledge^ (see Table 2). We used a very strict criterion
because the choice we offered is controversial, and we wanted
to maintain a high standard to evaluate our counseling. Michie
et al. used a midpoint score (4.5) on 8 knowledge questions for
knowledge to be qualified as sufficient. Thus, our criterion for
Bsufficient knowledge^ is stricter. This should be taken into
account when interpreting our results.
We developed the MIC questions based on the content of
the counseling participants received. During counseling, there
was a strong emphasis on explaining what the differences
between 0.5 Mb and 5 Mb testing were, and what the respec-
tive scopesmight andmight not detect, with realistic examples
of certain conditions. A team of clinical geneticists, psychol-
ogists and a statistician were involved with the development
of the questions. The attitude scale comprised six statements
with a 10-point response format and ranging from 1 (useless/
not important) to 10 (very useful/very important) (see
Table 3). A higher score indicated a more positive attitude
towards broader scope array (0.5 Mb), a lower score indicated
a more negative attitude. Based on design of the MMIC from
Marteau et al. (2001), we created three categories of outcomes
of informed choice; 1) completely informed (adequate knowl-
edge and consistent attitude), 2) partly uninformed (poor
knowledge and consistent attitude, or good knowledge and
inconsistent attitude) and 3) completely uninformed (poor
knowledge and inconsistent attitude), (see Fig. 3).
Decisional Ambivalence Scale
The questionnaire furthermore comprised the previously pub-
lished Decisional Ambivalence Scale (DAS; (Cronbach’s
α = .85) (van der Steen et al. 2014). The DAS contain ten
items that measure doubts and confidence regarding the
choice. All items had a 10-point response format and ranged
from 1 (not at all) to 10 (very much so). Summed scores on the
DAS can range from 10 to 100, with a higher score indicating
a higher level of experienced doubts.
STAI
Anxiety was measured using the short version of the Dutch
state trait anxiety inventory (STAI), which was validated for
pregnant women in the Netherlands(van der Bij et al. 2003).
The scores ranged from 1 (not at all) to 4 (very much so). STAI
total scores can range from 20 to 80. Higher scores indicate
greater feelings of anxiety (van der Steen et al. 2014).
Statistical Analyses
To obtain a larger sample, women engaging in PNS (hypo-
thetical choice) and PND (real choice) were both included in
our analyses. It should be noted that these are two different
groups of women, and that the PND group is a Bhigh stakes^
group compared to the PNS group, that has lower stakes.
Women in the PND group had made a real choice that led to
real prenatal test results, and therefore they could have, argu-
ably, paid more attention to the counseling. However, as there
were no statistically significant differences in informed choice
between the two groups of women, we analyzed the sample as
a whole.
Before analyzing the data for this study, assumptions for
ANOVAwere checked. A significance level of p < 0.05 was
used for all analyses. Outliers were detected, reverse-scored
items were recoded, and total scores were calculated. To ex-
amine the internal consistency of the MIC, Cronbach’s alpha
was used.
To assess whether participants made an informed choice,
we calculated total MIC Knowledge and Attitude scores.
Correct answers on the Knowledge scale were coded into
dichotomous scores (1 = correct; 0 = incorrect) 1, thus
summed to a maximum of 7 points. For the Attitude scale,
with six statements, scores ranged from 6 (very negative) to 60
(very positive). Those were summed and divided by 6 to pro-
duce an attitude score between 1 and 10. Similar to other
studies on this subject (Dahl et al. 2011; Kleinveld
et al. 2009; Michie et al. 2002), we employed a mid-
point score for the attitude scale; participants with an
attitude score below 5.5 were categorized as having a
negative attitude, scores above 5.5 were categorized as a
positive attitude. Attitudes were checked for their congruence
with the choice of array resolution. For example, if a partici-
pant indicated that knowledge about SL was important/useful,
0.5 Mb array resolution including disclosure of SL was ex-
pected as a choice. Attitudes were linked to choice of test for
(in)consistency.
To examine the relationship between nominal variables,
separate Pearson chi-square tests were used for decision out-
come and actual (PND) and hypothetical (PNS) choice, deci-
sion outcome and broad (0.5 Mb) or less broad (5 Mb) array,
and for decision outcome and wanting to be informed about
SL (+SL/−SL).
We assessed differences in background variables (age, lev-
el of education) for women making an informed vs. an unin-
formed choice using separate Pearson chi-square tests. Using
the decision outcome (completely informed/uninformed) as
dichotomous factors, we performed separate independent
samples t-tests for continuous variables (STAI/DAS total
scores) to test for differences between groups. To assess dif-
ferences in anxiety and doubts (DAS/STAI) between women
opting for or against disclosure of SL, independent t-tests were
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performed. For anxiety and doubts over time (T0 & T1), we
used paired samples t-tests.
Results
Demographic Variables
The mean age of women was 37.9 years. The demographic
variables (see Table 1) of women making informed or unin-
formed choices did not differ significantly, although the rela-
tionship between educational level and informed/uninformed
choices was marginally significant (p = 0.055).
Measure of Informed Choice
Tables 2 and 3 present the items and descriptives of the MIC
knowledge and attitude scales. The internal consistency reli-
ability of the MIC Knowledge scale was α = .55, which is
insufficient. This was caused by the fact that most women
answered the questions with the same answers, resulting in
lower variances, which led to a lower Cronbach’s alpha. The
MIC Attitude scale had a reliability of α = .78.
Figure 2 shows the percentage of correct and incorrect an-
swers for the MIC Knowledge questions (see Table 2 for the
specified questions). Most questions were answered correctly
by the majority of women. Question 3, BWhich diseases may
the less broad test detect?^ and question 6 BWhat is a suscep-
tibility locus?^ were answered correctly by approximately
50% of the women.
Informed Choice Outcomes
Figure 3 presents a pie chart of the outcomes of informed
choice. Overall, 62.3% made a completely informed choice.
A partly informed choice was made by 33.3% of women;
24.6% had poor knowledge, but a consistent attitude, and
8.7% had good knowledge, but an inconsistent attitude.
Lastly, 4.3% made a completely uninformed choice.
For statistical analyses, level of informed choice was di-
chotomized in two levels, informed and uninformed.
Relationship between Decision Outcome
and Demographic Variables
There was a marginally significant association between edu-
cational level and informed/uninformed choices (p = 0.055).
Women who had a higher educational level tended to be more
likely to make completely informed choices than women who
had a lower educational level. There were no other statistically
significant differences in demographic variables (see Table 2).
Relationship between Decision Outcome
and Actual/Hypothetical Choices
As mentioned earlier, there was no significant association be-
tween informed/uninformed choices and actual versus hypo-
thetical choice. Thus, women choosing for PNS or PNDmade
equally informed choices.
Relationship between Decision Outcome and Choosing
Broader or less Broad Testing
There was a significant association between informed/
uninformed choices and choice of array resolution χ2
(1) = 19.29, p < 0.001, V = 0.71 (large effect size),
OR = 0.36 (95% CI 0.17–0.79). Women who made a
completely informed choice, opted for broader testing more
often.
Relationship between Decision Outcome and Disclosure
of SL
There was no significant association between wanting to be
informed about SL and informed/uninformed choices. Thus,
women opting for or against disclosure of SL made equally
informed choices. There were no significant effects of wanting
to be informed of SL on either anxiety or doubts.
Anxiety & Doubts and Decision Outcome
There were no significant differences in anxiety level (STAI)
and informed versus uninformed choices. There was no sig-
nificant difference in levels of doubts (DAS) and informed
Table 1 Demographic characteristics of women who made informed
versus uninformed choices (N = 69)
Total Informed Uninformed p(χ2) *
N (%) N (%) N (%)
Previous children
Yes 42 (60) 25 (66) 17 (53) .28
No 28 (40) 13 (34) 15 (47)
Education
Low-intermediate 25 (35) 12 (29) 12 (46) .055
High 44 (65) 30 (71) 14 (54)
Nationality
Dutch 64 (93) 38 (88) 26 (100) .07
Other 5 (7) 5 (12)
Religious
Yes 17 (25) 11 (26) 6 (23) .83
No 51 (75) 31 (74) 20 (77)
Test type
PNS 39 (56) 22 (51) 17 (65) .25
PND 30 (44) 21 (49) 9 (35)
*2-sided Chi square tests performed.
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versus uninformed choices. Thus, there were no differences in
level of anxiety and doubts between women making informed
versus uninformed choices. Mean anxiety and doubt scores
for all women are displayed in Table 4.
There was a significant difference in anxiety (STAI) for
women opting for PNS versus PND. Women who opted for
PND, had a higher level of anxiety. There was no significant
difference in level of doubt for women opting for PNS versus
PND (see Table 5). There were no differences in anxiety and
doubts between women opting for or against disclosure of
susceptibility loci (see Table 6).
Overall the anxiety and doubt scores decreased significant-
ly between T1 and T2 (see Table 7). There were no significant
differences in the course of anxiety and doubts between in-
formed and uninformed decision-makers or between the PND
and PNS subgroups.
Discussion
The aim of the current study was to assess whether pregnant
women had sufficient knowledge to make an informed deci-
sion regarding the scope of their invasive prenatal genetic test
using SNP microarray that was consistent with their attitude.
Furthermore, we explored whether level of informed choice
was associated with anxiety and doubts.
Informed choice implies making a value-consistent deci-
sion based on sufficient knowledge. Although the majority
of women made a Bcompletely informed^ choice (sufficient
knowledge and consistent attitude), a substantial subgroup
made a choice that was at odds with their personal values.
Michie et al. (2002) showed that knowledge plays no role in
whether women undergo screening or whether they act in line
with their attitudes. Our study supports this finding; women
who did not have sufficient knowledge were able to make a
choice that was consistent with their attitudes, and vice versa.
A small percentage of women with sufficient knowledge were
still choosing value-inconsistently.
Anxiety and doubts were not higher in women who made
an uninformed choice. These findings are in contrast to previ-
ous studies showing that making uninformed choices is asso-
ciated with adverse psychological outcomes. Women who
made uninformed choices had more decisional conflicts/
doubts and felt more anxious when making a choice whether
or not to engage in prenatal screening (Dahl et al. 2011; van
den Berg et al. 2006). Therefore, we would have expected that
making an uninformed choice (lack of knowledge) might
bring more worries about choosing the right test, and that
Table 2 Item descriptives of
MIC knowledge scale, 7 items
(Cronbach’s. α = .55, N = 69)
Item (multiple choice) Incorrect/correct M SD
Q1. Which conditions can be excluded by CVS or AC? 0/1 .78 .42
Q2. What is the risk of having a miscarriage? 0/1 .82 .39
Q3. Which conditions may the less broad test detect? 0/1 .50 .50
Q4. Which conditions are not detectable with the less broad test? 0/1 .79 .41
Q5. Which conditions may the broad test detect? 0/1 .88 .33
Q6. What is a susceptibility locus? 0/1 .53 .50
Q7. What could be the added value of the broad test for pregnant women? 0/1 .79 .41
Total knowledge score 0–7 4.78 2.88
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Correct
Incorrect
Fig. 2 Percentage of women’s correct/incorrect answers on the MIC
Knowledge scale (N = 69)
Table 3 Item descriptives of MIC attitude scale(Cronbach’s. α = .78,
N = 69)
Item Range M SD
1. For me, knowledge about Down syndrome is…
a. (1) Not of added value… (10) Useful 1–10 8.86 1.64
b. (1) Unimportant… (10) Important 1–10 9.08 1.51
2. For me, knowledge about a small, but severe chromosomal
abnormality is…
a. (1) Not of added value… (10) Useful 1–10 9.00 1.39
b. (1) Unimportant… (10) Important 1–10 9.04 1.46
3. For me, knowledge about a susceptibility locus is…
a. (1) Not of added value… (10) Useful 1–10 6.45 3.29
b. (1) Unimportant… (10) Important 1–10 6.66 2.97
Total attitude score 6–60 47.90 11.1
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these worries may lead to more anxiety or stress.
Alternatively, it is possible that the women who made an un-
informed choice were not able to grasp the potential detrimen-
tal consequences of their choice. A lack of knowledge may
only be stressful if one is aware of what is lacking. The per-
centage of informed choices are concordant with other studies
on informed choice in prenatal screening, although those stud-
ies used less stringent criteria, such as the midpoint score
(Michie et al. 2002; Rowe et al. 2006; Schoonen et al. 2012).
The concepts of adequately informed and uninformed
choices are evident. However, partly informed choices lie in
a more Bgrey area,^ which needs to be reflected upon. We
found that most women who made partly informed choices
based their choice on insufficient knowledge but with a con-
sistent attitude. It could be argued that partly informed choices
can still be considered autonomous choices: women may not
need the complete detailed facts and specifications about the
test characteristics to make a choice that is in line with their
values (or an expression of self-determination). In line with
this, it may be argued that reproduction/recall of knowledge
after counseling is less of a condition for autonomous choice
than agreement with one’s personal values.
Choices based on sufficient knowledge, but with an incon-
sistent attitude, were less prevalent. In line with an earlier
study, our results show that knowledge indeed played no role
in whether or not the women acted in accordance with their
attitudes (Michie et al., 2003). We argue that value-
inconsistent choices might be the most worrisome type of
decision. If a woman chooses a scope of testing that does
not fit her personal values, despite having sufficient knowl-
edge about the test characteristics, this might lead to adverse
psychological outcomes. It has to be taken into account that
subtle signs of attitude inconsistency are easily missed. The
counselors’ preferences may have (inadvertently) influenced
the pregnant women’s decision-making, leading women to
make choices that were inconsistent with their own values
despite enough knowledge.
Actual versus Hypothetical Choices
No differences were found in the level of informed choice
between the PNS and PND groups. This might indicate that
women who made a hypothetical choice, have gone through a
similar decision (−making) process as women who underwent
PND. However, there is a difference between the women en-
gaging in PNS and PND: women engaging in PND made a
real choice that was actually performed by our lab, and thus
had higher stakes than women making a hypothetical choice
(PNS). Our results show that women opting for PND indeed
experienced more anxiety than women engaging in PNS. It
might be that level of anxiety is associated with informational
needs. Alternatively, it could be that women engaging in PND
are more anxious because of the miscarriage risk associated
with the invasive procedure (Muller and Cameron 2014). It
must be noted that in our sample 19% of the pregnant women
experienced anxiety at clinically relevant levels, and these
women were distributed equally across the PNS/PND groups.
At follow-up, four weeks later and after they received test
results, almost all anxiety scores were back to normal levels
(van der Bij et al. 2003), except for three women who experi-
enced enduring anxiety.
Fig. 3 Pie chart of decision outcomes of all women (N = 69)
Table 4 Mean anxiety (STAI) and doubts (DAS) score by decision
outcome for all women (N = 69)
Informed choice Uninformed choice t p
n = 37; 51% n = 32; 58%
Mean STAI score 34.05 34.95 n.s.
Mean DAS score 25.11 25.81 n.s.
Table 5 Mean anxiety (STAI) and doubts (DAS) score of women
opting for PND/PNS (N = 69)
PND PNS t p
n = 29 n = 40
Mean STAI score 37.20 33.75 6.802 .012
Mean DAS score 22.90 26.86 n.s.
Table 6 Mean anxiety (STAI) and doubts (DAS) score of women
opting for or against disclosure of susceptibility loci (SL) (N = 62)
+SL -SL t
n = 39 n = 23
Mean STAI score 36.49 32.22 n.s.
Mean DAS score 22.73 24.10 n.s.
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Broad or less Broad Microarray and Susceptibility Loci
Women who opted for broad scope PND made informed
choices significantly more often. Being fully aware of the
possible outcomes, they preferred to gain information about
susceptibility loci in their unborn child. This might be related
to the Bsense of personal ownership^ of genomic data
(Kimball et al. 2014). Patients may be inclined to want own-
ership and/or control over their – or in this case their baby’s -
genomic data. This may contribute to choosing a maximum of
information from a genomic test, even if that means the test
would include uncertain outcomes such as susceptibility loci
(van der Steen et al. 2014). Our first impressions were that
women in our clinic appeared to be able to handle this kind of
information (van der Steen et al. 2016). Moreover, women
indicated that they could use this kind of information in the
future, if their child would develop abnormally. They indicat-
ed that they would knowwhere to start looking for help and/or
mobilize adequate care.
The majority of well-informed women chose to be in-
formed of susceptibility loci if detected. The finding that the
majority of women make informed decisions about suscepti-
bility loci might seems in contrast with the often expressed
fear/concern among professionals that these results are too
difficult to grasp for patients (de Jong et al. 2009; de Jong
et al. 2013). However, the two positions are not mutually
exclusive. Women may be able to make an informed decision
at the time, but not able to fully grasp/understand the long-
term consequences of a rather abstract test outcome. On the
other hand, professionals might underestimate the resiliency
of their patients.We found that the women in our study did not
have a heightened level of anxiety compared to other Dutch
pregnant women at high risk of an abnormal fetus (van der Bij
et al. 2003). This finding is also incongruent with profes-
sionals’ worries of burdening pregnant women with an over-
load of information (de Jong et al. 2009; de Jong et al. 2013;
Dondorp et al. 2012; McGillivray et al. 2012).
In conclusion, despite all of the controversy regarding pre-
natal microarrays, our study shows that the majority of women
were capable of making an informed choice regarding the
scope of their invasive prenatal genetic test. And most impor-
tantly, they made informed choices in the absence of severe
anxiety or doubts. Our data have shown that overall levels of
anxiety and doubts decreased significantly over time, regard-
less of the choices (broad, less broad, SL or no SL) or level of
informed decision-making. This decreasing pattern of anxiety
is in accordancewith previous studies (van der Bij et al. 2003).
It should be noted that choice/consent cannot and need not
be completely informed (Manson and O'neill 2007). People
may differ with regard to their informational needs and the
level of detail they require for decision-making (Vos et al.
2013). For some, knowing that testing may generate
Binformation about severe, incurable conditions^ may be suf-
ficient, whereas others may need to know what conditions
exactly are included in the test, in order to make an informed
decision. To accommodate differences in informational needs
among individual women, pre-test counseling can be conduct-
ed in a layered fashion, where basic, crucial information is
offered to all women, and further, more detailed information
is given if needed or desired (Bunnik et al. 2013). The level of
knowledge required for informed choice, it can be argued,
may thus vary among individual decision-makers. Attitude
consistency, on the other hand, is less of a spectrum, but rather
a necessary condition for informed choice.
In the literature, efforts aimed at improving informed
choices mostly target the knowledge component (Schoonen
et al. 2011; Schoonen et al. 2011; Schoonen et al. 2012). We
stress the importance of attitude consistency, and recommend
that the choices of pregnant women regarding the scope of
their genetic test should fit their personal values well in order
to facilitate informed choice. Thus, interventions aimed at
improving informed choices through attitude consistency
may be more effective than those targeting knowledge only
(Michie et al. 2002; van den Berg et al. 2006). We suggest that
attitude and values need to be explored and discussed in the
pre-test counseling sessions.
The telephone counseling enabled the majority of women
to make an informed choice. It must be taken into account,
however, that this counselingwas extensive and time-consum-
ing, and therefore will not be feasible in everyday practice. It
would be interesting to compare the level of informed choices
with telephonic versus routine face-to-face counseling. Face-
to-face counseling has a more personal aspect, and therefore
might be capable of more adequately addressing attitude in-
consistency or miscomprehension.
The Future: The Expansion of Prenatal Genetic
Information
Prenatal screening and follow-up diagnostic testing are likely
to expand in the future, and to becomemore complex, as more
and more findings/conditions could be included in the test.
This might not only be possible with invasive testing, but also
with non-invasive prenatal test (NIPT). Some state that in
order to keep informed consent feasible, unnecessary compli-
cations should be avoided: screening should only be used for
Table 7 Mean anxiety (STAI) and doubts (DAS) score of women after
counseling (T0) and 4 weeks after disclosure of prenatal test results (T1)
(N = 69)
T0 T1 t p
n = 69 n = 69
Mean STAI score 35.03 26.82 5.390 <.001
Mean DAS score 23.86 18.32 5.134 <.001
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trisomies 13, 18 and 21. However, complications may not
always be unnecessary: tests may come to include other con-
ditions that are as relevant to women or couples in reproduc-
tive decision-making as is Down syndrome. Multiple studies
have shown that a majority of pregnant women prefer an in-
dividualized choice, and prefer to learn as much as possible
from prenatal tests (de Jong et al. 2013; van der Steen et al.
2014; van Schendel et al. 2015). Broadening the scope of
prenatal diagnosis should - at minimum - be considered. To
facilitate informed choices, pre-test counseling remains of
great importance. Since extensive face-to-face counseling
might not always be feasible, the next step may be to develop
decision-aids that comprise both knowledge and attitude and
personal values. This could be especially helpful for women
who may otherwise make choices that are inconsistent with
their attitudes. Such solutions and new models of informed
consent are more and more widely applied in healthcare sys-
tems, and they may indeed have the potential to improve com-
plex decision-making regarding the prenatal screening and
follow-up diagnostic testing offer (Vlemmix et al. 2013).
Strengths & Limitations
It should be noted that the women who present at the prenatal
clinic of our university medical center are of above-average
educational level. Furthermore, participating women were al-
ready motivated to seek prenatal screening or diagnosis (on
the basis of either advanced maternal age or abnormal first
trimester screening), and may thus be more inclined to prefer
to learn about genetic risks in their fetuses than other pregnant
women. Our results might be further biased due to the unequal
distribution of ethnicity; only 7% of the women was not
Dutch.
A strength of this study is that, to our knowledge, we are
the first to have assessed informed choice regarding invasive
PND performed with microarrays. Further, we allowed partic-
ipants to make an individualized choice of array resolution
that best suited their preferences.
Conclusion
We found that the majority of pregnant women were capable
of making an adequately informed choice about the scope of
invasive PND, including whether or not they wanted to be
informed of SL. A justified course of action based on this
result could be that laboratories perform broad analysis and
counselors provides patients with an opting in or out possibil-
ity. Knowledge has already been established as an important
component in informed choice. However, our study under-
lines that a consistent attitude might be equally important.
We anticipate that in the future, regardless of more complex
or new techniques, the majority of women will still be able to
make informed choices, as long as adequate information pro-
vision and counseling are provided. For counseling practices,
we advocate a stronger focus on attitude-consistency instead
of only a focus on knowledge.
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